As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

High-profile Republican priorities are advancing after the Iowa Legislature's first "funnel" deadline on Friday, while others ...

U.S. Customs and Border Protection has launched a new mobile app to give undocumented migrants, whose parole has been revoked ...

BOSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that the ...

Hims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food and Drug Administration (FDA) officially resolved the semaglutide shortage.

Patients with low-grade upper tract urothelial carcinoma receiving primary treatment with 6 once-weekly pyelocalyceal doses ...

The U.S. stock market is continuing to tumble amid President Trump's tariffs war and fears of a potential recession. Follow ...

Recently selected Food and Drug Administration chief lawyer Hilary K. Perkins has resigned from the job, according to a post ...